CG Oncology Shareholders Back Directors and Governance Proposals

CG Oncology shareholders elect Class II directors at annual meeting

CG Oncology director Leonard Post sells 1,000 shares for $54,500

CG Oncology to Present at Upcoming Investor Conferences in June

Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)

Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track

CG Oncology Chief Operating Officer Ambaw Bellete to Depart

CG Oncology announces departure of president, COO Ambaw Bellete

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Olema Pharmaceuticals (OLMA) and CG Oncology, Inc. (CGON)

Wolfe sees CG Oncology COO exit as operational, no impact to key programs

CG Oncology Inc - Appoints Arthur Kuan as President - SEC Filing

CG Oncology - Ambaw Bellete to Separate From Co as President & COO Effective June 30 - SEC Filing

CG Oncology names Arthur Kuan president after COO Ambaw Bellete exits

CG Oncology Initiated at Peer Perform by Wolfe Research

SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CG Oncology initiated with a Peer Perform at Wolfe Research

CG Oncology's Creto Combination Could Drive Better Efficacy in BCG-Exposed NMIBC, UBS Says

Wedbush Remains a Buy on CG Oncology, Inc. (CGON)

CG Oncology Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insulet (PODD), ProKidney (PROK) and CG Oncology, Inc. (CGON)